MUSSETTI, ALBERTO

MUSSETTI, ALBERTO  

Universita' degli Studi di MILANO  

Mostra records
Risultati 1 - 12 di 12 (tempo di esecuzione: 0.009 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
Editorial: Novel treatments for diffuse large B-cell lymphoma: The post-CART era 2022 Mussetti, AlbertoDerenzini, Enrico + Article (author) -
Handling the COVID-19 pandemic in the oncological setting 2020 Mussetti A.Corradini P. + Article (author) -
Ocular disorders in multiple myeloma patients: cross-sectional study of prevalence and association with treatment 2018 Pennisi, MartinaMussetti, AlbertoCACIOPPO, VIVIANADAVID, ALESSANDROCorradini, Paolo + Article (author) -
CD3+ graft cell count influence on chronic GVHD in haploidentical allogeneic transplantation using post-transplant cyclophosphamide 2018 Mussetti, A.de Philippis, C.Carniti, C.Cieri, N.Pennisi, M.Ciceri, F.Mariotti, J.Castagna, L.Corradini, P. + Article (author) -
Treatment of classical Hodgkin lymphoma in the era of brentuximab vedotin and immune checkpoint inhibitors 2018 P. CorradiniA. Mussetti + Article (author) -
New drugs and allogeneic hematopoietic stem cell transplantation for hematological malignancies: do they have a role in bridging, consolidating or conditioning transplantation treatment? 2017 F. OnidaL. CastagnaA. MussettiR. GrecoP. CorradiniA. Rambaldi + Article (author) -
Next-generation sequencing of a family with a high penetrance of monoclonal gammopathies for the identification of candidate risk alleles 2017 N. BolliM. BarcellaE. SalviF. D'AvilaA. VendraminC. De PhilippisA. MussettiF. MauraC. BarlassinaP. Corradini + Article (author) -
Haploidentical allogeneic hematopoietic cell transplantation for multiple myeloma using post transplant cyclophosphamide GVHD prophylaxis 2017 L. CastagnaA. MussettiF. MauraC. de PhilippisP. Corradini + Article (author) -
Post-transplant cyclophosphamide, a promising anti-graft versus host disease prophylaxis : where do we stand? 2017 A. MussettiGRECO, RAFFAELLAP. Corradini + Article (author) -
Allogeneic Stem Cell Transplantation for Relapsed/Refractory B-Cell Lymphomas: Results of a Multicenter Phase II Prospective Trial Including Rituximab in the Reduced Intensity Conditioning Regimen 2017 F. BarrettaA. MussettiF. OnidaL. FarinaA. RambaldiP. Corradini + Article (author) -
Recurrent Hodgkin lymphoma : toward a new definition of candidates for autologous stem cell transplant in the era of positron emission tomography scan and novel agents 2015 P. CorradiniA. Mussetti + Article (author) -
Bortezomib plus dexamethasone followed by escalating donor lymphocyte infusions for patients with multiple myeloma relapsing or progressing after allogeneic stem cell transplantation 2013 F. SpinaA. MussettiP. Corradini + Article (author) -